CO4870792A1 - Compuestos y conjunto de medios de diagnostico para detectar y vigilar la progresion de cancer de prostata - Google Patents
Compuestos y conjunto de medios de diagnostico para detectar y vigilar la progresion de cancer de prostataInfo
- Publication number
- CO4870792A1 CO4870792A1 CO98010253A CO98010253A CO4870792A1 CO 4870792 A1 CO4870792 A1 CO 4870792A1 CO 98010253 A CO98010253 A CO 98010253A CO 98010253 A CO98010253 A CO 98010253A CO 4870792 A1 CO4870792 A1 CO 4870792A1
- Authority
- CO
- Colombia
- Prior art keywords
- polypeptide
- nucleotide sequences
- patient
- protein
- prostate
- Prior art date
Links
- 206010060862 Prostate cancer Diseases 0.000 title abstract 5
- 208000000236 Prostatic Neoplasms Diseases 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 title 1
- 201000001514 prostate carcinoma Diseases 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 8
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 8
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 8
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 7
- 102000004169 proteins and genes Human genes 0.000 abstract 6
- 108090000623 proteins and genes Proteins 0.000 abstract 6
- 239000011230 binding agent Substances 0.000 abstract 4
- 108020004414 DNA Proteins 0.000 abstract 3
- 102000053602 DNA Human genes 0.000 abstract 3
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 2
- 239000012472 biological sample Substances 0.000 abstract 2
- 230000002163 immunogen Effects 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 210000002307 prostate Anatomy 0.000 abstract 2
- 239000000523 sample Substances 0.000 abstract 2
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57434—Specifically defined cancers of prostate
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pathology (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80659697A | 1997-02-25 | 1997-02-25 | |
| US90480997A | 1997-08-01 | 1997-08-01 | |
| US2074798A | 1998-02-09 | 1998-02-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO4870792A1 true CO4870792A1 (es) | 1999-12-27 |
Family
ID=27361502
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO98010253A CO4870792A1 (es) | 1997-02-25 | 1998-02-25 | Compuestos y conjunto de medios de diagnostico para detectar y vigilar la progresion de cancer de prostata |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6887660B2 (enExample) |
| EP (2) | EP1630235A3 (enExample) |
| JP (4) | JP3844366B2 (enExample) |
| AR (1) | AR012035A1 (enExample) |
| AT (1) | ATE302414T1 (enExample) |
| BR (1) | BR9807734A (enExample) |
| CA (1) | CA2281954A1 (enExample) |
| CO (1) | CO4870792A1 (enExample) |
| DE (1) | DE69831222T2 (enExample) |
| DK (1) | DK0972201T3 (enExample) |
| ES (1) | ES2248891T3 (enExample) |
| IL (1) | IL131539A0 (enExample) |
| WO (1) | WO1998037418A2 (enExample) |
Families Citing this family (85)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7202342B1 (en) | 1999-11-12 | 2007-04-10 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
| US20030185830A1 (en) | 1997-02-25 | 2003-10-02 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
| BR9808881A (pt) | 1997-02-25 | 2001-09-11 | Corixa Corp | Compostos para imunoterapia de câncer de próstata e métodos para seu uso |
| US6329505B1 (en) | 1997-02-25 | 2001-12-11 | Corixa Corporation | Compositions and methods for therapy and diagnosis of prostate cancer |
| US6800746B2 (en) | 1997-02-25 | 2004-10-05 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
| US6261562B1 (en) | 1997-02-25 | 2001-07-17 | Corixa Corporation | Compounds for immunotherapy of prostate cancer and methods for their use |
| US6630305B1 (en) | 1999-11-12 | 2003-10-07 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
| US7517952B1 (en) | 1997-02-25 | 2009-04-14 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
| US6620922B1 (en) | 1997-02-25 | 2003-09-16 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
| US6818751B1 (en) | 1997-08-01 | 2004-11-16 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
| US6943236B2 (en) | 1997-02-25 | 2005-09-13 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
| US6465611B1 (en) | 1997-02-25 | 2002-10-15 | Corixa Corporation | Compounds for immunotherapy of prostate cancer and methods for their use |
| US7033827B2 (en) | 1997-02-25 | 2006-04-25 | Corixa Corporation | Prostate-specific polynucleotide compositions |
| US6894146B1 (en) | 1997-02-25 | 2005-05-17 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
| US7270980B2 (en) * | 1997-02-25 | 2007-09-18 | Corixa Corporation | Compounds for immunodiagnosis of prostate cancer and methods for their use |
| US6395278B1 (en) | 1997-02-25 | 2002-05-28 | Corixa Corporation | Prostate specific fusion protein compositions |
| US6613872B1 (en) | 1997-02-25 | 2003-09-02 | Corixa Corporation | Compounds for immunotherapy of prostate cancer and methods for their use |
| US6759515B1 (en) | 1997-02-25 | 2004-07-06 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
| US6365369B1 (en) | 1998-04-01 | 2002-04-02 | Human Genome Sciences, Inc. | Prostate specific secreted protein |
| US6048970A (en) * | 1998-05-22 | 2000-04-11 | Incyte Pharmaceuticals, Inc. | Prostate growth-associated membrane proteins |
| US7037667B1 (en) | 1998-06-01 | 2006-05-02 | Agensys, Inc. | Tumor antigen useful in diagnosis and therapy of prostate and colon cancer |
| ATE437947T1 (de) | 1998-06-01 | 2009-08-15 | Agensys Inc | Serpentintransmembranantigene exprimiert in menschlichem krebs und deren verwendungen |
| JP2002517185A (ja) * | 1998-06-01 | 2002-06-18 | アジェンシス，インコーポレイテッド | 前立腺癌および結腸癌の診断および治療に有用な腫瘍抗原 |
| US20060052321A1 (en) | 2002-04-05 | 2006-03-09 | Raitano Arthur B | Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer |
| US20030149531A1 (en) | 2000-12-06 | 2003-08-07 | Hubert Rene S. | Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| US6833438B1 (en) | 1999-06-01 | 2004-12-21 | Agensys, Inc. | Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| US20040141975A1 (en) | 1998-06-01 | 2004-07-22 | Raitano Arthur B. | Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer |
| AU762812B2 (en) * | 1998-07-14 | 2003-07-03 | Corixa Corporation | Compositions and methods for therapy and diagnosis of prostate cancer |
| EP1117794A2 (en) * | 1998-10-02 | 2001-07-25 | Urogenesys, Inc. | Human gene expressed in cancers of prostate, bladder, pancreas and colon, 36p1a6 |
| US6902892B1 (en) | 1998-10-19 | 2005-06-07 | Diadexus, Inc. | Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| EP1724351A3 (en) * | 1999-03-11 | 2007-11-14 | Mount Sinai Hospital | Human Kallikrein-like genes |
| US7022497B1 (en) * | 1999-03-11 | 2006-04-04 | Mt. Sinai Hospital | Human kallikrein-like genes |
| AU5416700A (en) * | 1999-05-20 | 2000-12-12 | Fahri Saatcioglu | Differentially expressed genes in prostate cancer |
| CO5450246A1 (es) * | 1999-07-13 | 2004-10-29 | Smithkline Beecham Corp | Vacuna |
| EP1212354A2 (en) * | 1999-09-10 | 2002-06-12 | Corixa Corporation | Ovarian tumor sequences and methods of use therefor |
| US6720146B2 (en) | 1999-09-10 | 2004-04-13 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of ovarian cancer |
| US6613515B1 (en) | 1999-09-10 | 2003-09-02 | Corixa Corporation | Ovarian tumor sequences and methods of use therefor |
| US6617109B1 (en) | 1999-09-10 | 2003-09-09 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of ovarian cancer |
| US20030232056A1 (en) | 1999-09-10 | 2003-12-18 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of ovarian cancer |
| US6710170B2 (en) | 1999-09-10 | 2004-03-23 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of ovarian cancer |
| GB9922835D0 (en) * | 1999-09-25 | 1999-11-24 | Smithkline Beecham Biolog | Novel compounds |
| AU7994200A (en) * | 1999-10-04 | 2001-05-10 | Corixa Corporation | Compositions and methods for therapy and diagnosis of prostate cancer |
| EP1220931A1 (en) * | 1999-10-07 | 2002-07-10 | Schering Aktiengesellschaft | Dna encoding prost 07 polypeptide |
| CA2391369A1 (en) * | 1999-11-12 | 2001-05-17 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
| KR20030016217A (ko) * | 2000-01-14 | 2003-02-26 | 코릭사 코포레이션 | 전립선 암의 치료 및 진단을 위한 조성물 및 방법 |
| US7611892B2 (en) | 2000-03-24 | 2009-11-03 | President And Fellows Of Harvard College | Prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| WO2001073032A2 (en) * | 2000-03-27 | 2001-10-04 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
| RU2276672C2 (ru) * | 2000-04-10 | 2006-05-20 | Институт Биоорганической химии им. акад. М.М. Шемякина и Ю.А. Овчинникова Российской Академии Наук | Антитело к фактору hldf, способ его получения (варианты), пептид с антигенными и нк-гидролизующими свойствами и способ диагностики анапластического состояния клетки человека |
| WO2001077682A1 (fr) * | 2000-04-10 | 2001-10-18 | Institut Bioorganicheskoi Khimii Imeni Akademikov M.M. Shemyakina I Ju. A. Ovchinnikova Rossiisskoi Akademii Nauk | Anticorps diriges contre le facteur hldf, procedes de fabrication correspondants, peptides avec des capacites antigeniques et a hydrolyse hk et procede de diagnostic de l'etat anaplasique de cellules humaines |
| DK2266603T3 (da) | 2000-10-18 | 2012-11-05 | Glaxosmithkline Biolog Sa | Tumorvacciner |
| PL365605A1 (en) | 2000-11-28 | 2005-01-10 | Wyeth | Expression analysis of fkbp nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| AU2002236503C1 (en) | 2000-11-28 | 2008-11-13 | Wyeth | Expression analysis of KIAA nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| JP2005505271A (ja) | 2001-09-06 | 2005-02-24 | アジェンシス， インコーポレイテッド | 癌の処置および検出において有用なｓｔｅａｐ−１と名称が与えられる核酸および対応するタンパク質 |
| US7494646B2 (en) | 2001-09-06 | 2009-02-24 | Agensys, Inc. | Antibodies and molecules derived therefrom that bind to STEAP-1 proteins |
| US20040162236A1 (en) * | 2002-04-01 | 2004-08-19 | John Alsobrook | Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| EP1792912A3 (en) * | 2002-04-02 | 2007-08-29 | Curagen Corporation | Novel proteins and nucleic acids encoding same |
| AU2003279696A1 (en) * | 2002-05-14 | 2004-02-23 | Fidelity Systems, Inc. | Helix-hairpin-helix motifs to manipulate properties of dna processing enzymes |
| US20080153104A1 (en) | 2003-08-08 | 2008-06-26 | Hiroyuki Aburantai | Gene Overexpressed in Cancer |
| US7276408B2 (en) * | 2003-10-08 | 2007-10-02 | Texas Instruments Incorporated | Reduction of dopant loss in a gate structure |
| WO2005062977A2 (en) * | 2003-12-23 | 2005-07-14 | The Regents Of The University Of California | Prostate cancer specific internalizing human antibodies |
| PL1742966T3 (pl) | 2004-04-22 | 2014-04-30 | Agensys Inc | Przeciwciała i pochodzące z nich cząsteczki, które wiążą się z białkami STEAP-1 |
| TWI457133B (zh) | 2005-12-13 | 2014-10-21 | Glaxosmithkline Biolog Sa | 新穎組合物 |
| DK2468300T3 (da) | 2006-09-26 | 2018-01-29 | Infectious Disease Res Inst | Vaccinesammensætning indeholdende syntetisk adjuvant |
| US20090181078A1 (en) | 2006-09-26 | 2009-07-16 | Infectious Disease Research Institute | Vaccine composition containing synthetic adjuvant |
| EP2845866B1 (en) | 2006-10-27 | 2017-05-03 | Genentech, Inc. | Antibodies and immunoconjugates and uses therefor |
| JP5830015B2 (ja) | 2009-06-05 | 2015-12-09 | インフェクシャス ディズィーズ リサーチ インスティチュート | 合成グルコピラノシル脂質アジュバント |
| BR112013020875A2 (pt) | 2011-02-15 | 2019-09-24 | Immune Design Corp | método para indução de uma resposta imune específica para um imunógeno em um indivíduo. |
| BR112013025799A2 (pt) | 2011-04-08 | 2016-12-20 | Immune Design Corp | método para induzir uma resposta imune em um sujeito, e, preparação |
| PL2811981T3 (pl) | 2012-02-07 | 2019-09-30 | Infectious Disease Research Institute | Ulepszone formulacje adiuwantowe zawierające agonistę TLR4 oraz sposoby ich zastosowania |
| PT2850431T (pt) | 2012-05-16 | 2018-07-23 | Immune Design Corp | Vacinas para hsv-2 |
| MX370573B (es) | 2013-04-18 | 2019-12-17 | Immune Design Corp | Monoterapia con glucopiranosil lipido a para usarse en el tratamiento del cancer. |
| US9463198B2 (en) | 2013-06-04 | 2016-10-11 | Infectious Disease Research Institute | Compositions and methods for reducing or preventing metastasis |
| IL310015B1 (en) | 2013-12-31 | 2025-10-01 | Access To Advanced Health Inst | Single vial formulation |
| US20170196954A1 (en) | 2014-07-15 | 2017-07-13 | Immune Design Corp. | Prime-boost regimens with a tlr4 agonist adjuvant and a lentiviral vector |
| US11162945B2 (en) | 2016-04-11 | 2021-11-02 | Board Of Regents, The University Of Texas System | Methods and compositions for detecting single T cell receptor affinity and sequence |
| MX2018013640A (es) | 2016-05-16 | 2019-08-01 | Infectious Disease Res Inst | Liposomas pegiladas y metodos de uso. |
| DK3458475T3 (da) | 2016-05-16 | 2022-09-12 | Access To Advanced Health Inst | Formulering, der indeholder tlr-agonist, og anvendelsesfremgangsmåder |
| MX385732B (es) | 2016-06-01 | 2025-03-18 | Infectious Disease Res Inst | Partículas de nanoalumbre que contienen un agente de dimensionamiento. |
| MX2019011769A (es) | 2017-04-03 | 2019-11-07 | Hoffmann La Roche | Anticuerpos que se unen a steap-1. |
| BR112019026615B1 (pt) | 2017-06-15 | 2022-08-02 | Infectious Disease Research Institute | Carreadores lipídicos nanoestruturados e emulsões estáveis e usos dos mesmos |
| JP7339942B2 (ja) | 2017-09-08 | 2023-09-06 | アクセス ツー アドバンスト ヘルス インスティチュート | サポニンを含むリポソーム製剤および使用方法 |
| EP3976092A1 (en) | 2019-05-25 | 2022-04-06 | Infectious Disease Research Institute | Composition and method for spray drying an adjuvant vaccine emulsion |
| US20230310323A1 (en) | 2020-09-04 | 2023-10-05 | Access To Advanced Health Institute | Co-lyophilized rna and nanostructured lipid carrier |
| WO2022051024A1 (en) | 2020-09-04 | 2022-03-10 | Infectious Disease Research Institute | Genetically-adjuvanted rna vaccines |
| CA3173408A1 (en) | 2020-12-23 | 2022-06-30 | Access To Advanced Health Institute | Solanesol vaccine adjuvants and methods of preparing same |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5851764A (en) * | 1990-10-25 | 1998-12-22 | The Trustees Of Columbia University In The City Of New York | Human prostate tumor inducing gene-1 and uses thereof |
| WO1993014753A1 (en) | 1992-01-27 | 1993-08-05 | The Board Of Trustees Of The Leland Stanford Junior University | Histamine derivatives and methods for their use |
| WO1993014775A1 (en) * | 1992-01-31 | 1993-08-05 | Wright George L Jr | Monoclonal antibody pd41 and antigen associated with prostate adenocarcinomas |
| US5428011A (en) | 1992-06-16 | 1995-06-27 | Procyon Biopharma, Inc. | Pharmaceutical preparations for inhibiting tumours associated with prostate adenocarcinoma |
| US5786148A (en) | 1996-11-05 | 1998-07-28 | Incyte Pharmaceuticals, Inc. | Polynucleotides encoding a novel prostate-specific kallikrein |
| EP0668777B2 (en) * | 1992-11-05 | 2011-02-09 | Sloan-Kettering Institute For Cancer Research | Prostate-specific membrane antigen |
| ATE303160T1 (de) * | 1993-08-11 | 2005-09-15 | Jenner Technologies | Impfstoff gegen prostatakrebs |
| EP0652014A1 (en) | 1993-11-10 | 1995-05-10 | National Institute Of Immunology | Treatment of prostatic hypertrophy |
| WO1995030758A1 (en) | 1994-05-10 | 1995-11-16 | Mayo Foundation For Medical Education And Research | Recombinant hk2 polypeptide |
| WO1998050567A1 (en) * | 1997-05-02 | 1998-11-12 | Abbott Laboratories | Reagents and methods useful for detecting diseases of the prostate |
-
1998
- 1998-02-25 US US09/030,606 patent/US6887660B2/en not_active Expired - Fee Related
- 1998-02-25 DK DK98911411T patent/DK0972201T3/da active
- 1998-02-25 BR BR9807734-1A patent/BR9807734A/pt not_active Application Discontinuation
- 1998-02-25 EP EP05017792A patent/EP1630235A3/en not_active Withdrawn
- 1998-02-25 AT AT98911411T patent/ATE302414T1/de not_active IP Right Cessation
- 1998-02-25 WO PCT/US1998/003690 patent/WO1998037418A2/en not_active Ceased
- 1998-02-25 JP JP53700898A patent/JP3844366B2/ja not_active Expired - Lifetime
- 1998-02-25 EP EP98911411A patent/EP0972201B1/en not_active Expired - Lifetime
- 1998-02-25 IL IL13153998A patent/IL131539A0/xx unknown
- 1998-02-25 ES ES98911411T patent/ES2248891T3/es not_active Expired - Lifetime
- 1998-02-25 CA CA002281954A patent/CA2281954A1/en not_active Abandoned
- 1998-02-25 AR ARP980100837A patent/AR012035A1/es active IP Right Grant
- 1998-02-25 DE DE69831222T patent/DE69831222T2/de not_active Expired - Lifetime
- 1998-02-25 CO CO98010253A patent/CO4870792A1/es unknown
-
2006
- 2006-04-10 JP JP2006107887A patent/JP2006201187A/ja not_active Ceased
-
2007
- 2007-01-10 JP JP2007002906A patent/JP2007114212A/ja active Pending
-
2008
- 2008-07-01 JP JP2008172191A patent/JP2008249727A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DE69831222D1 (de) | 2005-09-22 |
| JP2006201187A (ja) | 2006-08-03 |
| JP2001513886A (ja) | 2001-09-04 |
| AR012035A1 (es) | 2000-09-27 |
| WO1998037418A3 (en) | 1999-02-25 |
| US6887660B2 (en) | 2005-05-03 |
| EP1630235A3 (en) | 2009-05-27 |
| EP0972201A2 (en) | 2000-01-19 |
| JP3844366B2 (ja) | 2006-11-08 |
| CA2281954A1 (en) | 1998-08-27 |
| BR9807734A (pt) | 2000-10-31 |
| IL131539A0 (en) | 2001-01-28 |
| DK0972201T3 (da) | 2006-01-02 |
| EP0972201B1 (en) | 2005-08-17 |
| JP2007114212A (ja) | 2007-05-10 |
| US20020081580A1 (en) | 2002-06-27 |
| ATE302414T1 (de) | 2005-09-15 |
| WO1998037418A2 (en) | 1998-08-27 |
| ES2248891T3 (es) | 2006-03-16 |
| JP2008249727A (ja) | 2008-10-16 |
| DE69831222T2 (de) | 2006-07-13 |
| EP1630235A2 (en) | 2006-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO4870792A1 (es) | Compuestos y conjunto de medios de diagnostico para detectar y vigilar la progresion de cancer de prostata | |
| BR9908567A (pt) | Processos de detecção de ácido nucléico zimogênico e moléculas relacionadas e kits | |
| TR200000113T2 (tr) | Tüberkülozu teşhis etmek için bileşikler ve bunları kullanma yöntemleri. | |
| SE9500023L (sv) | Sätt att detektera cancer | |
| ATE426018T1 (de) | Pca3, pca3-gene und verfahren zu ihrer verwendung | |
| JP2008249727A5 (enExample) | ||
| DE69636075D1 (de) | Verbindungen und verfahren zur diagnose von tuberkulose | |
| TR199901569T2 (xx) | T�berk�lozun te�hisi i�in bile�ikler ve y�ntemler. | |
| DE69334071D1 (de) | Prostata-spezifisches membranantigen | |
| BR0112602A (pt) | Compostos e métodos para tratamento e diagnóstico de infecção clamidial | |
| DK0914344T3 (da) | Assay og reagenser til kvantificering af hBNP | |
| ES2052607T3 (es) | Metodos y kits para detectar secuencias de acidos nucleicos. | |
| DE60043944D1 (de) | Zytokin zcyt018 | |
| CA2362527A1 (en) | A novel, prostate-specific gene for diagnosis, prognosis and management of prostate cancer | |
| EA200000845A1 (ru) | Ген, кодирующий новый маркер рака | |
| ATE433463T1 (de) | Monospezifische antikörper gegen fibrinogen und fibrinopeptide b | |
| WO1999018210A3 (en) | Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer | |
| DE502004008729D1 (de) | Gegen das Prothrombin-Fragment F1+2 gerichtete Antikörper, ihre Herstellung und Verwendung | |
| EP1580265A4 (en) | FROM A NEUROBLASTOM IN STAGE 4S ISOLATED LUCES | |
| DE60131962D1 (de) | Verfahren und zusammensetzungen zum nachweis von taenia solium larven mittels eines klonierten antigens | |
| RU2206574C2 (ru) | Полипептид, содержащий антигенный участок растворимого антигена м. tuberculosis, способ (варианты) и диагностический набор (варианты) для выявления инфекции m. tuberculosis | |
| JP2003532369A5 (enExample) | ||
| ATE440968T1 (de) | Verfahren zur diagnostizierung von aspirinunverträglichkeit | |
| WO2001010897A3 (en) | Methods and compositions for detecting larval taenia solium | |
| ATE158815T1 (de) | Hippurikasegen |